The trading price of Nuvation Bio Inc (NYSE:NUVB) closed lower on Monday, August 5, closing at $3.18, -5.36% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $4.16 and a 52-week low of $0.95. Over the past month, the stock has gained 4.95% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Nuvation Bio Inc, whose market valuation is $792.62 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest NUVB has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that NUVB’s price is currently -6.66% off the SMA20 and 1.25% off the SMA50. The RSI metric on the 14-day chart is currently showing 45.44, and weekly volatility stands at 10.79%. When measured over the past 30 days, the indicator reaches 7.32%. Nuvation Bio Inc (NYSE:NUVB)’s beta value is currently sitting at 1.42, while the Average True Range indicator is currently displaying 0.28.
To see how Nuvation Bio Inc stock has been performing in comparison to its peers in the industry, here are the numbers: NUVB stock’s performance was -5.36% in the latest trading, and 80.68% in the past year.
An evaluation of the daily trading volume of Nuvation Bio Inc (NYSE:NUVB) indicates that the 3-month average is 1.61 million.
Currently, records show that 218.05 million of the company’s shares remain outstanding. The insiders hold 34.23% of outstanding shares, whereas institutions hold 48.92%. However, since the stock’s price has seen 110.60% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
